Changing the Conversation About Mental Health: Patient & Provider Perspectives is a series of conversations that explores the need to openly and honestly discuss mental health topics to help bridge the communications gap that can exist between health care providers and people with mental health disorders. Throughout this podcast, a clinician and a person with MDD engage in a conversation about a different aspect of MDD – from the journey to diagnosis to the impact of MDD.

The information in this podcast is not intended to serve as medical advice or substitute for consultation with a healthcare professional. If you or someone you know is experiencing depression or thoughts of suicide, please seek immediate treatment and/or call the National Suicide Prevention Lifeline by dialing 988 or the full number at 1-800-273-8255. Please note the views of the participants discussed on this podcast may not be representative of the views of other providers or individuals living with MDD.

This podcast series was sponsored by Sage Therapeutics, Inc. and Biogen Inc.

The Sage and Biogen names and logos are registered trademarks of their respective owners.
MRC-MDD-00447 …

Diagnosing patients with peripheral spondyloarthritis (pSpA) can often be challenging, particularly when differentiating it from other causes of inflammatory and non-inflammatory arthritis. So what is the role of ultrasound when diagnosing pSpA in patients? Join Dr. Ethan Craig as he guides this discussion with Dr. Catherine Bakewell, Rheumatologist at Intermountain Healthcare in Salt Lake City, Utah.

Dr. Craig and Dr. Bakewell are Novartis Consultants.

269162 3/23

Technology is advancing exponentially, and this has been more evident than ever in the field of medicine. In fact, biotech and pharmaceutical companies are bringing biology and technology together to better meet patient needs across a range of specialties. So what are the latest research and initiatives in digital health that are working towards a future of more personalized medicine for patients with multiple sclerosis (MS)? Joining Dr. Turck to share insights on digital health innovations in MS care is Dr. Shibeshih Belachew, Head of Science at Biogen Digital Health.

© 2023 Biogen. All rights reserved.

There’s been a lot of focus recently on biosimilars and their potential role in evolving the healthcare system. We're digging in deeper to understand what makes biosimilars so exciting. Joining Dr. Jennifer Caudle to discuss the biosimilar approval process and the important commitment supporting healthcare providers and patients in their adoption is a panel of experts: Dr. Stefanie Cribb, Dr. Ira Steinberg, and Ms. Jennifer Rubin from Coherus Biosciences and Dr. Ryan Haumschild from the Emory Healthcare and Winship Cancer Institute.

© 2022 Coherus BioSciences
C1122-COH-P829

The COVID-19 pandemic impacted the way contraceptive care was offered to patients, with many offices turning to telemedicine.1 Telemedicine can be used while still offering long-acting reversible contraception (LARC) options by implementing a hybrid model for care.2,3 This type of approach consists first of a telemedicine appointment to counsel patients on all appropriate contraceptive options and, if necessary, an in-person appointment to initiate any contraceptive method that requires placement by a healthcare provider.2,3 To learn more about how you can incorporate this model into your practice, tune in to hear Dr. Edmund Kim share his approach and how the use of a hybrid model has enabled him to continue to offer all contraceptive options, including LARCs.2-4

References:
1. Comfort AB, Rao L, Goodman S, et al. Assessing differences in contraceptive provision through telemedicine among reproductive health providers during the COVID-19 pandemic in the United States. Reprod Health. 2022;19(1):99.

2. Stifani BM, Madden T, Micks E, et al. Society of Family Planning clinical recommendations: contraceptive care in the context of pandemic response. Contraception. 2022;113:1–12.

3. Prioritization of in-person and virtual visits during COVID-19: a decision-making guide for staff. Family Planning National Training Center. Accessed December 15, 2022.

Addressing obesity may be a key component of diabetes management, so integrating strategies to manage obesity may improve diabetes care. To better understand this, Dr. Jamy Ard and Dr. Michelle Cardel dive into the impact of evidence-based lifestyle interventions for people living with diabetes.

WW Logo and Weight Watchers are the trademarks of
WW International, Inc. and are used with permission.

Polygenic autoinflammatory diseases can present in several ways, such as in still’s disease and systemic juvenile idiopathic arthritis. To share key insights on these diseases, Dr. Jason Liebowitz is joined by Dr. Bella Mehta from Cornell Medical College.

Dr. Liebowitz and Dr. Mehta are Novartis consultants.

10/22

As recent research demonstrates the important role that TSLP plays in asthma inflammation, Dr Matt Birnholz is joined by Dr Jonathan Corren, an Associate Clinical Professor of Medicine and Pediatrics at David Geffen School of Medicine in Los Angeles. Together, they review how TSLP acts across the spectrum of asthma inflammation, the correlation of TSLP with clinical features of asthma, and more.

Clinicians are still working to understand the mechanisms behind age-related declines and what interventions might help promote healthy aging. Could supplementation with the nutritional compounds glycine and n-acetylcysteine (GlyNAC) play a role by improving intracellular antioxidant levels? Dr. Rajagopal Sekhar shares the latest clinical data on GlyNAC supplementation in older adults.

From therapeutic options to potential outcomes, what factors should we consider when escalating treatment for patients with axial spondyloarthritis? Dr. Ethan Craig is joined by Dr. Lianne Gensler from the UCSF Spondylitis Clinic at the University of California San Francisco Medical Center to dive into these key considerations.

Dr. Craig and Dr. Gensler are Novartis consultants.

11/22